David has worked for international institutions including the Apoptotic Center Research Unit of CHEO Research Institute in Ottawa, Canada, and the MRC Toxicology Unit in Leicester, United Kingdom, where he successfully led international and collaborative projects related to apoptosis, aptamers, and characterization of the oligonucleotide-protein interactions to identify potential therapeutic targets. He has spent more than 15 years working on molecular biology and cell signaling projects, focusing on gene expression, protein synthesis regulation, and its functionality. David holds a PhD in Biochemistry and Molecular Biology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices